International Drug Regulatory Mechanisms

by Wertheimer; Albert I

• ISBN13: 9780789025487
• ISBN10: 0789025485
• Edition: 1st
• Format: Hardcover
• Copyright: 2004-08-16
• Publisher: CRC Press

Summary

Learn how international governments have committed themselves to improving access to quality health care! International Drug Regulatory Mechanisms explores the environment, organization, structure, functioning, and finance of health systems and pharmaceutical markets in 19 countries. Local experts describe each country's experiences with and lessons learned from the regulation of pharmaceutical products. This book will help government officials, pharmacy educators, and pharmaceutical industry leaders from around the globe identify and develop successful methods for controlling pharmaceutical drug prices and utilization. In International Drug Regulatory Mechanisms, you will learn about the health care system of each country and each government's measures to control drug costs. This text shows you what government interventions are feasible as well as effective, and the impact of these measures on consumers, government agencies, and the pharmaceutical companies and distributors. Drug policies, reimbursement concepts, and health insurance companies are all examined to give you a better working knowledge of the methodology and guidelines involving drug control in nations such as: Iceland Canada Israel Malaysia Argentina Taiwan Mexico Italy International Drug Regulatory Mechanisms is an extensive text that shows how pharmaceuticals are regulated throughout the world. This book examines how--despite similar goals--price controls, utilization controls, record keeping, and quality requirements differ greatly between countries. Using numerous graphs, tables, and figures, this one-of-a-kind resouce provides you with new insight into which strategies are superior and how to implement these strategies in your own country.

Table of Contents

Foreword	xi
Greg Perkins
Interventions to Curb Rising Pharmaceutical Costs in Iceland	1	(22)
Anna Birna Almarsdóttir
Almar Grimsson
Ingunn Björnsdóttir
Canadian Public Policies and Practices Related to Drug Prices, Utilization and Expenditures	23	(32)
Ingrid Sketris
Susan Bowles
Richard Manuel
Drug Policy in the Czech Republic	55	(22)
Lenka Praznovcova
Josef Suchopar
Albert I. Wertheimer
Drug Policies and Pricing Mechanism: The Malaysian Perspective	77	(18)
Mohamed Izham Mohamed Ibrahim
Salmah Bahri
Drug Pricing in South Africa-Policy and Praxis	95	(28)
Andy Gray
Thulani Matsebula
Drug Price Control in India-An Overview	123	(10)
Mansi B. Shah
Arnit S. Patel
Pharmaceutical Benefit Scheme and Cost Containment in Taiwan's National Health Insurance	133	(18)
Weng-Foung Huang
Hung-Chi Chiang
Rx Price Control Methods in Mexico	151	(30)
Jaime Kravzov-Jinich
Marina Altagracia-Martinez
Martha Elena Yamasaki-López
Hector Salgado-Schoelly
Claudia Cardona-Carlin
Financing Pharmaceutical Care in the Dutch Health System	181	(8)
Han de Gier
Drug Pricing Policy in Hungary	189	(16)
Zoltáan Vincze
Romána Zelkó
Agnes Mészáros
Germany's Attempts to Control Drug Prices and Expenditures: Success or Failure?	205	(30)
Eva Susanne Dietrich
Regulating the Prices and Costs of Medicines in the United Kingdom	235	(26)
David Taylor
The Controls of Prices of Medicines in Israel	261	(8)
Avi Moshenson
Howard Rice
Pharmaceutical Services in Slovenia	269	(6)
Jurij Fürst
Pricing and Reimbursement of Medicinal Products in Denmark	275	(20)
Karen Kolenda
Henrik Vestergaard
Drug Prices in Argentina	295	(12)
Marcelo J. Vernengo
Ricardo Bolaños
Drug Pricing and Reimbursement System in Turkey	307	(16)
Selen Yegenoglu
Medication Expenditure and Utilization in Morocco	323	(14)
Batoul Senhaji
Pharmaceutical Expenditure: Aspects of Cost Containment in Italy	337	(14)
Luciana Scalone
Simona de Portu
Paola Minghetti
Lorenzo G. Mantovani
Organization of Health Care Systems and Financing of Pharmaceuticals in Norway, Including Cost Containments	351	(10)
Geir Bredesen
Index	361